Attending BioFIT? ITR will be there!

Whether you’re an academic spin-off, biotech start-up or emerging pharma company with early-stage assets, we offer integrated preclinical services (in vitro, in vivo, in silico; GLP-compliant, BSL-2 capable) to help de-risk, validate and accelerate your candidate from discovery toward IND readiness.

Interested in outsourcing your next in vivo tox, PK/PD or regulatory-compliant safety study? Schedule a meeting with Ilan Rose at BioFIT and let ITR support your journey from bench to clinic.